持続的腎代替療法（CRRT）の市場規模、シェア、成長分析：製品別、モダリティ別、年齢層別、エンドユーザー別、地域別 - 産業予測、2024-2031年

持続的腎代替療法（CRRT）の世界市場規模は2022年に13億米ドルと評価され、2023年の14億米ドルから2031年には26億1,000万米ドルに達し、予測期間（2024-2031年）のCAGRで8.1％の成長が予測されています。

持続的腎代替療法（CRRT）市場は、主にCOVID-19患者の急性腎障害（AKI）症例の急増に牽引され、CRRTの需要が以前の集団の5倍に達したと報告されており、大幅な成長が見込まれています。パンデミック中のこのような利用増加は、CRRTと慢性腎臓病（CKD）に対する認識を高めるためのメーカーと政府の積極的な取り組みによってさらに後押しされています。パンデミックはまた、現地のメーカーに有利な環境を作り出し、高度なCRRTデバイスに対する需要の高まりにつながりました。さらに、小児用CRRT製品の進歩が市場の拡大をさらに促進すると予想されます。米国は、AKIの高い有病率と多数の病院を擁する強固な医療インフラの恩恵を受けて、CRRT市場の支配的な地位を維持しています。これに加え、AKIに関連した入院患者数の増加や末期腎疾患の罹患率の増加が、この地域における市場成長の強力な基盤となっています。このような動向から、米国CRRT市場は今後予測期間においても安定したCAGRを維持すると予測され、ヘルスケア分野の利害関係者にとって有望な展望が開けています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• 特許分析
• 貿易分析
• 技術分析
• バリューチェーン分析
• 顧客と購買基準の分析

持続的腎代替療法（CRRT）市場：製品別

• 市場概要
• 透析液および補充液
• 消耗品
  • 血液濾過器
  • 血統セット・チューブ
  • その他
• CRRTシステム

持続的腎代替療法（CRRT）市場：モダリティ別

• 市場概要
• 持続的静脈血液濾過
• 持続的静脈血液濾過透析
• 持続的静脈血液透析
• 緩徐持続的限外濾過

持続的腎代替療法（CRRT）市場：年齢層別

• 市場概要
• 成人
• 小児・新生児

持続的腎代替療法（CRRT）市場：エンドユーザー別

• 市場概要
• 病院
• 外来診療
• 在宅医療
• その他

持続的腎代替療法（CRRT）市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Baxter International, Inc.（US）
• Fresenius Medical Care AG & Co. KGaA（Germany）
• Nikkiso Co., Ltd.（Japan）
• B. Braun Melsungen AG（Germany）
• Medtronic PLC（Ireland）
• Asahi Kasei Corporation（Japan）
• Toray Medical Co., Ltd.（Japan）
• Nipro Corporation（Japan）
• Infomed SA（Switzerland）
• Medica SPA（Italy）
• Medites Pharma Spol. S.R.O.（Czech Republic）
• Medical Components, Inc.（US）
• SWS Hemodialysis Care Co., Ltd.（China）
• Ningbo Tianyi Medical Devices Co., Ltd.（China）
• Anjue Medical Equipment Co., Ltd.（China）
• Kimal（UK）
• Jiangxi Sanxin Medtech Co., Ltd.（China）
• Allmed Medical Products Co., Ltd.（China）
• Dialco Medical Inc.（US）
• Browndove Healthcare Pvt. Ltd.（India）
• Steris PLC（US）
• Kuraray Medical PLC（Japan）
• Livanova PLC（UK）
• Diaverum Deutschland GmbH（Germany）
• Sembcorp Industries（Singapore）

Global Continuous Renal Replacement Therapy Market size was valued at USD 1.30 billion in 2022 and is poised to grow from USD 1.40 billion in 2023 to USD 2.61 billion by 2031, growing at a CAGR of 8.1% in the forecast period (2024-2031).

The Continuous Renal Replacement Therapy (CRRT) market is poised for substantial growth, driven primarily by the surge in Acute Kidney Injury (AKI) cases among COVID-19 patients, with demand for CRRT reported to be five times higher than in previous populations. This increase in utilization during the pandemic has been further bolstered by proactive initiatives from both manufacturers and governments to raise awareness about CRRT and chronic kidney disease (CKD). The pandemic has also created a favorable environment for local manufacturers and led to heightened demand for advanced CRRT devices, largely due to the increasing prevalence of fluid overload and the pursuit of improved patient outcomes. Additionally, advancements in pediatric CRRT products are expected to propel market expansion further. The U.S. remains the dominant player in the CRRT market, benefiting from a high prevalence of AKI and a robust healthcare infrastructure characterized by numerous hospitals. This is compounded by the rising hospital admissions linked to AKI and the growing incidence of end-stage renal disease, providing a strong foundation for market growth in the region. As these trends unfold, the U.S. CRRT market is projected to sustain a steady compound annual growth rate (CAGR) in the forthcoming forecast period, highlighting a promising outlook for stakeholders in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the global continuous renal replacement therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global continuous renal replacement therapy Market Segmental Analysis

Global Continuous Renal Replacement Therapy Market is segmented on the product, modality, age group, end user, and region. By product, market is segmented into dialysate & replacement fluids, disposables, and CRRT Systems. By modality, market is segmented into continuous venovenous hemofiltration, continuous venovenous hemodiafiltration, continuous venovenous hemodialysis, and slow continuous ultrafiltration. By age group, market is segmented into adults, and pediatrics & neonates. By end user, market is segmented into hospitals, ambulatory care, home care, and other end users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the global continuous renal replacement therapy Market

The increasing prevalence of acute kidney injury (AKI) serves as a significant market driver for the global continuous renal replacement therapy (CRRT) market. With a rise in cases particularly among critically ill patients and individuals with pre-existing health conditions, the demand for effective renal replacement therapies is surging. AKI is frequently encountered in intensive care units, where CRRT is the preferred method due to its ability to provide continuous and controlled dialysis in unstable patients. This uptick in AKI cases not only elevates the need for CRRT devices and consumables but also enhances market growth opportunities for manufacturers and healthcare providers alike, as timely intervention is crucial for improving patient outcomes.

Restraints in the global continuous renal replacement therapy Market

The high cost of Continuous Renal Replacement Therapy (CRRT) represents a significant market restraint, particularly in regions with constrained healthcare resources and budgets. The expenses associated with CRRT treatment-including sophisticated equipment, consumables, and the need for specialized healthcare professionals-can create a financial barrier for hospitals and clinics, limiting their ability to implement these advanced therapies. Consequently, many healthcare facilities may be unable to adopt or sustain CRRT, reducing patient access to this critical treatment option. This financial strain not only hinders the adoption of CRRT but also stifles overall market growth by restricting outreach to underserved populations.

Market Trends of the global continuous renal replacement therapy Market

The global Continuous Renal Replacement Therapy (CRRT) market is witnessing significant growth driven by several interconnected trends. A surge in acute kidney injury (AKI) and chronic kidney disease (CKD) cases, particularly among the aging population and those with comorbid conditions like diabetes and hypertension, is propelling the demand for CRRT devices and consumables. Additionally, technological innovations are enhancing the efficiency and user experience of CRRT machines, with features like electronic medical record connectivity and remote monitoring improving patient outcomes. Furthermore, the trend towards home-based CRRT is gaining traction, emphasizing patient convenience and potentially lowering healthcare costs. Together, these trends highlight a robust market evolution towards advanced, patient-centric renal care solutions.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Patent Analysis
• Trade Analysis
• Technology Analysis
• Value Chain Analysis
• Customer & Buying Criteria Analysis

Continuous Renal Replacement Therapy Market, By Product

• Market Overview
• Dialysate & Replacement Fluids
• Disposables
  • Hemofilters
  • Bloodline Sets & Tubes
  • Other Disposables
• CRRT Systems

Continuous Renal Replacement Therapy Market, By Modality

• Market Overview
• Continuous Venovenous Hemofiltration
• Continuous Venovenous Hemodiafiltration
• Continuous Venovenous Hemodialysis
• Slow Continuous Ultrafiltration

Continuous Renal Replacement Therapy Market, By Age Group

• Market Overview
• Adults
• Pediatrics & Neonates

Continuous Renal Replacement Therapy Market, By End User

• Market Overview
• Hospitals
• Ambulatory Care
• Home Care
• Other End Users

Continuous Renal Replacement Therapy Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Baxter International, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toray Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infomed SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica SPA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medites Pharma Spol. S.R.O. (Czech Republic)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medical Components, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SWS Hemodialysis Care Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ningbo Tianyi Medical Devices Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anjue Medical Equipment Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kimal (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangxi Sanxin Medtech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allmed Medical Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dialco Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Browndove Healthcare Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Steris PLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuraray Medical PLC (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Livanova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diaverum Deutschland GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sembcorp Industries (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments